Hematology and Oncology

Home Hematology and Oncology
For adolescent and young adult patients with Hodgkin lymphoma

Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers

Treatment strategies differ, but outcomes equivalent among adolescent, young adult Hodgkin patients
For children and young adults receiving CD19 chimeric antigen receptor T-cell infusion

Infection Risk Up in Month After CAR T-Cell Immunotherapy

Infection rates increase in patients with ALL aged ≤26 years in first month, then decrease at days 29 to 90
A total of 9.5 percent of persons were uninsured from January through June 2019

9.5 Percent Uninsured in U.S. From January Through June 2019

Overall, 13.7 percent of adults aged 18 to 64, 4.4 percent of children aged 0 to 17 were uninsured
Women with screening-detected ductal carcinoma in situ have increased long-term risks for invasive breast cancer and breast cancer death

Risk for Later Invasive Breast Cancer Up for Women With DCIS

Risks for invasive breast cancer, death from breast cancer higher for up to 20 years following diagnosis
There are extensive financial relationships between leaders of U.S. professional medical associations and industry

Links Found Between Leaders of Medical Associations, Industry

Most leaders have ties to industry; considerable variation seen among 10 medical associations in U.S.
Lung cancer patients who are given the opportunity to be informed of their diagnosis have a longer median survival time

Early Informed Lung Cancer Patients Have Greater Survival Rates

Predicted survival time for patients who were unaware of their diagnosis was poor
In 2018

Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services

Wide regional variation seen for availability of telehealth outpatient visits, tele-ICU services
Colorectal cancer incidence and mortality are reduced for a period of 17.4 years following a single negative screening colonoscopy

Lasting Drop Seen in CRC Incidence, Death After Negative Colonoscopy

Reductions only seen for 10.1 to 17.4 years of follow-up after high-quality colonoscopy
For patients with advanced-stage pancreatic ductal adenocarcinoma

Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects

PFS longer in pancreatic ductal adenocarcinoma with versus without homologous recombination deficiency
Modest delays in cancer surgery due to the COVID-19 pandemic could have a significant impact on survival

Delays in Cancer Surgery Due to COVID-19 Could Harm Survival

Per-patient delay of three or six months would result in an estimated 92,214 or 208,275 life-years lost